Dana Pizzuti

Insider Reports History

Entity
Individual
Location
C/O Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Building 2, San Diego, CA
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dana Pizzuti:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Chief Med and Dev Officer Common Stock 28.5K $1.56M $54.63 Oct 3, 2024 Direct
Crinetics Pharmaceuticals, Inc. Chief Med and Dev Officer Stock option (Right to Buy) 139K Oct 3, 2024 Direct

Insider Reports Filed by Dana Pizzuti

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRNX Crinetics Pharmaceuticals, Inc. Oct 3, 2024 3 -$543K 4 Oct 7, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Jul 3, 2024 3 -$402K 4 Jul 5, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Jun 24, 2024 3 -$274K 4 Jun 25, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Apr 15, 2024 3 -$396K 4 Apr 17, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Mar 20, 2024 7 -$422K 4 Mar 22, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Mar 18, 2024 1 -$15.7K 4 Mar 20, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Mar 4, 2024 2 $0 4 Mar 6, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Jan 3, 2024 3 -$260K 4 Jan 4, 2024 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Dec 21, 2023 3 -$169K 4 Dec 22, 2023 Chief Med and Dev Officer
CRNX Crinetics Pharmaceuticals, Inc. Apr 3, 2023 2 -$201K 4 Apr 5, 2023 Chief Development Officer
CRNX Crinetics Pharmaceuticals, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 Chief Development Officer
CRNX Crinetics Pharmaceuticals, Inc. Oct 10, 2022 2 $0 4 Oct 11, 2022 Chief Development Officer
CRNX Crinetics Pharmaceuticals, Inc. Sep 30, 2022 0 $0 3 Oct 11, 2022 Chief Development Officer